arrow
N

Nick J. Edwards

university of oxford
H指数:42
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection

重复受控人体疟疾感染后对 *Plasmodium vivax* 的临床免疫发展

2025-09-250
OAAI
Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infection

恶性疟原虫感染诱导T细胞耐受,该耐受与再感染时疾病严重程度降低相关。

2025-04-111
OA
High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response

高分辨率非洲HLA资源揭示了疫苗反应背后的HLA-DRB1表达效应

2024-05-130
OAAI
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens
2024-01-172
OAAI
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
2023-07-1216
OAAI
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials

两剂ChAdOx1 nCov-19 (AZD1222) 后免疫反应的持续性: 两项随机对照试验的1年随访

2023-02-028
OAAI
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection
2022-10-1346
OAAI
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics
2022-08-226
OAAI
Controlled human malaria infection with a clone of Plasmodium vivax with high- quality genome assembly
2021-12-0817
OA
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial

ChAd63/MVA Pfs25-IMX313在第一阶段人体试验中的安全性和免疫原性

2021-07-1426
OAAI
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination

RH5疫苗接种后人类血液阶段疟疾生长和免疫相关性降低

MED
IF11.8
2021-06-0185
OAAI
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (vol 27, pg 279, 2021)
2021-05-066
OAAI
Mapping immune variation and var gene switching in naive hosts infected with Plasmodium falciparum
2021-03-0221
OAAI
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
2020-12-17233
OAAI
A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates
2019-04-2656
OAAI